Superluminal Medicines Email Formats

Biotechnology Research • 15 Necco St, Lilly Gateway Labs, United States • 21-50 Employees

Superluminal Medicines Email Formats

Superluminal Medicines uses 1 email format. The most common is {first name}.{last name} (e.g., john.doe@superluminalrx.com), used 100% of the time.

Format	Example	Percentage
{first name}.{last name}	john.doe@superluminalrx.com	100%

Key Contacts at Superluminal Medicines

Ajay Yekkirala

Co-Founder & Svp, Head Of Discovery And Development

Nathan Genung

Director, Medicinal Chemistry

Ken Borrelli

Senior Director Computational Chemistry

Mark Fitzgerald

Director Of Chemistry

Katelyn Billings

Associate Director, Program Management

Florentina Tofoleanu

Associate Director

Marek Orzechowski

Senior Director Of Computational Chemistry

Xin Sun

Associate Director, Biology

Neil Lajkiewicz

Associate Director

Min-Sun Park

Associate Director, Computational Chemistry

Company overview

Headquarters	15 Necco St, Lilly Gateway Labs, 4th Floor, Boston, Massachusetts 02210, US
Website	superluminalrx.com
NAICS	541714
Employees	21-50
Socials

About Superluminal Medicines

Superluminal Medicines is a Boston-based generative biology and chemistry company developing a differentiated pipeline and revolutionizing the speed and accuracy of how medicine is created. Our platform creates candidate-ready compounds with unprecedented speed using a comprehensive combination of deep biology and chemistry expertise, machine learning, and proprietary big data infrastructure. The predict-design-test architecture accurately models protein shapes and designs highly selective compounds to target the precise structural change for therapeutic effect. Our discovery engine is powered by an industry-leading, pharmacokinetic and toxicology in silico prediction capability. With a lead program candidate expected in the near term, our proprietary pipeline validates our platform with initial programs focused on high-value GPCR targets. We’re pleased to be backed by a strong network of investors including RA Capital Management, Insight Partners, NVentures, Catalio Capital Management, Eli Lilly and Company, Gaingels, and Cooley LLP.

Employees by Management Level

Total employees: 21-50

Seniority

Employees

Director

Entry

Senior

Employees by Department

Superluminal Medicines has 21 employees across 8 departments.

Departments

Number of employees

Funding Data

Explore Superluminal Medicines's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount
2023-09-28	3	$33,000,000
2024-10-09	4	$120,000,000
2025-09-14	19	N/A

Funding Insights

$153,000,000

Total funding amount

Number of funding rounds

Superluminal Medicines Tech Stack

Discover the technologies and tools that power Superluminal Medicines's digital infrastructure, from frameworks to analytics platforms.

Cloudflare

CDN

Google Hosted Libraries

CDN

Cloudflare Bot Management

Security

jQuery

JavaScript libraries

HTTP/3

Miscellaneous

PHP

Programming languages

WordPress

Blogs

Bootstrap

UI frameworks

MySQL

Databases

WP Engine

Hosting

Google Font API

Font scripts

Frequently asked questions

Superluminal Medicines is located in 15 Necco St, Lilly Gateway Labs, US.

Superluminal Medicines has approximately 21-50 employees. The company continues to grow its workforce to support its business operations and expansion.

Superluminal Medicines has raised a total of $153,000,000 across 3 funding rounds. This investment has helped the company grow and expand its operations.